Header Logo

Connection

Annette Langer-Gould to Natalizumab

Back to Details
This is a "connection" page, showing publications Annette Langer-Gould has written about Natalizumab.
Annette Langer-Gould
Connection Strength
1.244
Natalizumab
  1. Multiple Sclerosis, Disease-Modifying Therapies, and Infections. Neurol Neuroimmunol Neuroinflamm. 2023 Nov; 10(6).
    View in: PubMed
    Score: 0.234
  2. Disease activity in pregnancy and postpartum in women with MS who suspended rituximab and natalizumab. Neurol Neuroimmunol Neuroinflamm. 2020 11; 7(6).
    View in: PubMed
    Score: 0.191
  3. Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients. Ann Neurol. 2020 05; 87(5):688-699.
    View in: PubMed
    Score: 0.183
  4. Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies. JAMA Neurol. 2020 02 01; 77(2):184-191.
    View in: PubMed
    Score: 0.181
  5. Pregnancy and Family Planning in Multiple Sclerosis. Continuum (Minneap Minn). 2019 Jun; 25(3):773-792.
    View in: PubMed
    Score: 0.173
  6. Progressive multifocal leukoencephalopathy and multiple sclerosis: lessons from natalizumab. Curr Neurol Neurosci Rep. 2006 May; 6(3):253-8.
    View in: PubMed
    Score: 0.070
  7. What went wrong in the natalizumab trials? Lancet. 2006 Mar 04; 367(9512):708-10.
    View in: PubMed
    Score: 0.069
  8. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med. 2005 Jul 28; 353(4):375-81.
    View in: PubMed
    Score: 0.066
  9. Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder. Neurol Neuroimmunol Neuroinflamm. 2020 07 02; 7(4).
    View in: PubMed
    Score: 0.046
  10. Natalizumab use during the third trimester of pregnancy. JAMA Neurol. 2014 Jul 01; 71(7):891-5.
    View in: PubMed
    Score: 0.031

© 2024 Kaiser Permanente